Zhejiang Shengda Bio-Pharm Co., Ltd.

Shanghai Stock Exchange 603079.SS

Zhejiang Shengda Bio-Pharm Co., Ltd. Current Liabilities for the year ending December 31, 2023: USD 41.61 M

Zhejiang Shengda Bio-Pharm Co., Ltd. Current Liabilities is USD 41.61 M for the year ending December 31, 2023, a -2.80% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

Zhejiang Shengda Bio-Pharm Co., Ltd. Current Liabilities for the year ending December 31, 2022 was USD 42.82 M, a -34.05% change year over year.
Zhejiang Shengda Bio-Pharm Co., Ltd. Current Liabilities for the year ending December 31, 2021 was USD 64.92 M, a 18.12% change year over year.
Zhejiang Shengda Bio-Pharm Co., Ltd. Current Liabilities for the year ending December 31, 2020 was USD 54.96 M, a 3.02% change year over year.
Zhejiang Shengda Bio-Pharm Co., Ltd. Current Liabilities for the year ending December 31, 2019 was USD 53.35 M, a -11.97% change year over year.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

Shanghai Stock Exchange: 603079.SS

Zhejiang Shengda Bio-Pharm Co., Ltd.

CEO	Mr. Bin Zhou
IPO Date	Aug. 23, 2017
Location	China
Headquarters	No. 789, Renmin East Road
Employees	1,032
Sector	Consumers Staples
Industries Pet Food Baby & Childcare Dairy & Milk Fertilizers Frozen Foods Organic Foods Personal Care Plastics

Description

Zhejiang Shengda Bio-Pharm Co., Ltd. engages in the research, development, production, and sale of food and feed additives worldwide. The company offers vitamins, such as biotin and folic acid, etc.; biological fresh-keeping agents, including nisin and natamycin; and intermediate APIs. It also produces natural food preservatives. The company is based in Tiantai, China.

Key trends

Past 5 years